POSITRON EMISSION TOMOGRAPHY-EVALUATION OF DOPAMINERGIC PATHWAYS

被引：0
|
作者：
PERLMUTTER, JS [1 ]
机构：
[1] WASHINGTON UNIV,SCH MED,DEPT NEUROL & NEUROL SURG NEUROL,ST LOUIS,MO
来源：
CLINICAL NEUROPHARMACOLOGY | 1995年 / 18卷
关键词：
POSITRON EMISSION TOMOGRAPHY; DOPAMINE; PARKINSONS DISEASE; RECEPTORS; TRANSMITTERS;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Positron emission tomography (PET) studies of dopamine receptors have provided exciting new insights into basal ganglia function that are particularly relevant to Parkinson's disease. Previous studies have concentrated on alterations in radioligand binding of primarily D-2-like dopaminergic binding sites. Development of new radioligands with greater dopamine subtype specificity promises to reveal additional information about dopaminergic function. Also, pharmacological activation techniques with PET may permit identification of alterations in receptor-mediated pathways not associated with direct changes in receptors.
引用
收藏
页码：S188 / S194
页数：7
相关论文
共 50 条
  • [41] Imaging Biological Pathways in Abdominal Aortic Aneurysms Using Positron Emission Tomography
    Bell, Michael
    Gandhi, Richa
    Shawer, Heba
    Tsoumpas, Charalampos
    Bailey, Marc A.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2021, 41 (05) : 1596 - 1606
  • [42] The Use and Misuse of Positron Emission Tomography in Lung Cancer Evaluation
    Chang, Ching-Fei
    Rashtian, Afshin
    Gould, Michael K.
    CLINICS IN CHEST MEDICINE, 2011, 32 (04) : 749 - +
  • [43] The utilization of positron emission tomography in the evaluation of renal health and disease
    Kwame Anokye Amoabeng
    Sanna Laurila
    Luis Eduardo Juárez-Orozco
    Anne Beate Langeland Marthinsen
    Dariusz Moczulski
    Eleni Rebelos
    Prince Dadson
    Clinical and Translational Imaging, 2022, 10 : 59 - 69
  • [44] The utility of positron emission tomography in the evaluation of autoimmune hearing loss
    Mazlumzadeh, M
    Lowe, VJ
    Mullan, BP
    Fabry, DA
    McDonald, TJ
    Matteson, EL
    OTOLOGY & NEUROTOLOGY, 2003, 24 (02) : 201 - 204
  • [45] Positron Emission Tomography in Schizophrenia: A New Perspective
    Patel, Neva H.
    Vyas, Nora S.
    Puri, Basant K.
    Nijran, Kuldip S.
    Al-Nahhas, Adil
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (04) : 511 - 520
  • [46] Positron emission tomography in Parkinson's disease
    Muthane, U
    NIMHANS JOURNAL, 1997, 15 (04): : 379 - 383
  • [47] Positron emission tomography in neurological and psychiatric disorders
    Newberg, Andrew
    Monti, Daniel
    Moss, Aleeze
    Alavi, Abass
    INTERNATIONAL JOURNAL OF IMAGING SYSTEMS AND TECHNOLOGY, 2012, 22 (01) : 2 - 17
  • [48] Advances in positron emission tomography imaging tracers for the central dopamine system
    Zhang Ge
    Yang Wenjiang
    Liu Yu
    CHINESE JOURNAL OF INORGANIC CHEMISTRY, 2024, 40 (01) : 54 - 70
  • [49] Positron Emission Tomography in Diagnosis and Differential Diagnosis of Parkinson's Disease
    Tatsch, Klaus
    NEURODEGENERATIVE DISEASES, 2010, 7 (05) : 330 - 340
  • [50] Dopaminergic effects after chronic treatment with nandrolone visualized in rat brain by positron emission tomography
    Kindlundh, AMS
    Bergström, M
    Monazzam, A
    Hallberg, M
    Blomqvist, G
    Långström, B
    Nyberg, F
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2002, 26 (7-8) : 1303 - 1308
12345